Related Articles
PEFA Newsletter: May 2021
PSYCHIATRY EDUCATION FORUM ACADEMY’S NEWSLETTER MAY 2021 Here is the summary of topics posted in the month of May at Psychiatry Education Forum Academy. These…
Augmentation Strategies for Major Depressive Disorder
PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: MAJOR DEPRESSIVE DISORDER: 10 AUGMENTATION STRATEGIES Introduction Psychiatry Education Forum Academy continues to provide high-quality, evidence-based & practice-oriented discussions…
Lithium Adverse Events Management
Psychiatry Education Forum Academy just finished the lecture series on Understanding Lithium’s Adverse Events Management. Here we have discussed the clinical details of how to…
Managing Clozapine Adverse Events
Clozapine was FDA-approved for treatment-refractory schizophrenia in 1989 and has remained the gold standard treatment since then for this indication. Clozapine has established efficacy in…
Journal Club #1: Update on Nonpsychotic Unipolar Depression Management
We begin PEFA Journal Club’s updated schedule with our first journal club discussion today: Journal Club #1: The Psychopharmacology Algorithm Project at the Harvard South…